The HER2-positive, as other BC, constitutes a heterogeneous group which can be subdivided, according to ER status, in HER2-positive/ER(−) and HER2-positive/ER(+) reflecting the stage of differentiation and the cell origin [5]. The gene discussed is ERBB2; the disease is breast cancer.